Prolonged tacrolimus in renal transplant patients management


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Clinical trials of efficacy and safety of prolonged tacrolimus in renal transplant patients are reviewed. Standard and prolonged tacrolimus demonstrate equal clinical efficacy and safety, but prolonged tacrolimus is associated with higher treatment adherence.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. Svistunov

V. Fomin

Email: FOMIN_VIC@MAIL.RU

Әдебиет тізімі

  1. Gentile S., Beauger D., Speyer E. et al. Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France// Health Qual Life Outcomes. - Vol. 30;11(1). - P. 88. [Epub ahead of print]
  2. Maglakelidze N., Pantsulaia T., Tchokhonelidze I. et al. Assessment of health-related quality of life in renal transplant recipients and dialysis patients // Transplant Proc. - 2011. - Vol. 43(1). - P. 376-379.
  3. Chisholm-Burns M.A., Erickson S.R., Spivey C.A. et al. Health-related quality of life and employment among renal transplant recipients // Clin Transplant. - 2012. - Vol. 26(3). - P. 411-417.
  4. Totti V, Zancanaro M., Trerotola M. et al. Quality of life and energy expenditure in transplant recipient football players // Transplant Proc. - 2013. - Vol. 45(7). - P. 2758-2760.
  5. Calia R., Lai C., Aceto P. et al. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation // Transplant Proc. - 2011. - Vol. 43(4). - P. 1020-1023.
  6. Kuypers D.R., Peeters P.C., Sennesael.JJ. et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring/ADMIRAD Study Team// Transplantation. -2013. - Vol. 95(2). - P. 333-340.
  7. Krämer B.K., Charpentier B., Bäckman L. et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study / Tacrolimus Prolonged Release Renal Study Group // Am J Transplant. - 2010. - Vol. 10(12). - P. 2632-2643.
  8. Iaria G., Sforza D., Angelico R. et al. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation // Transplant Proc. - 2011. - Vol. 43(4). - P. 1028-1029.
  9. Nakamura Y., Hama K., Katayama H. et al. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients // Transplant Proc. - 2012. - Vol. 44(1). - P. 124-127.
  10. Midtvedt K., Jenssen T., Hartmann A. et al. No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus //Nephrol Dial Transplant. - 2011. - Vol. 26(11). -P. 3767-3772.
  11. Weiler N., Thrun I., Eberlin M. et al. Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release?
  12. Kurnatowska I., Krawczyk J., Oleksik T. et al. Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus // Transplant Proc. - 2011. - Vol. 43(8). - P. 2954-2956.
  13. Bunnapradist S., Ciechanowski K., West-Thielke P. et al. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial/ MELT investigators// Am J Transplant. -2013. - Vol. 13(3). - P. 760-769.
  14. Gaber A.O., Alloway R.R., Bodziak K. et al. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients// Transplantation. - 2013. -Vol. 96(2). - P. 191-197.
  15. Fanous H., Zheng R., Campbell C. et al. A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study // Clin Kidney J. - 2013. - Vol. 6(1). -P. 45-49.
  16. Kitada H., Okabe Y., Nishiki T. et al. One-year follow-up of treatment with once-daily tacrolimus in de novo renal transplant // Exp Clin Transplant. - 2012. - Vol. 10(6). - P. 561-567.
  17. Slatinska J., Rohal T., Wohlfahrtova M. et al. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large singlecenter experience // Transplant Proc. - 2013. - Vol. 45(4). - P. 1491-1496.
  18. Uchida J., Kuwabara N., Machida Y. et al. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism // Transplant Proc. - 2012. - Vol. 44(1). - P. 128-133.
  19. Wu S.W., Tsai H.C., Tsai P.Y. et al. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients // Swiss Med Wkly. - 2013. - Vol. 143. - P. w13850.
  20. Guirado L., Cantarell C., Franco A. et al. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients / GREAT Study Group // Am J Transplant. - 2011. -Vol. 11(9). - P. 1965-1971.
  21. Tsuchiya T., Ishida H., Tanabe T. et al. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus // Transplantation. - 2013. - Vol. 96(2). - P. 198-204.
  22. Kolonko A., Chudek J., Wiecek A. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation // Transplant Proc. - 2011. - Vol. 43(8). - P. 2950-2953.
  23. Carcas-Sansuán A.J., Espinosa-Román L., Almeida-Paulo G.N. et al. Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up // Pediatr Nephrol. - 2013 Aug 2. [Epub ahead of print].
  24. Albano L., Banas B., Klempnauer J.L. et al. On behalf of the Optimising immuno Suppression After Kidney transplantation with ADVAGRAF (OSAKA) study group. OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation // Transplantation. - 2013 Aug 26. [Epub ahead of print].
  25. Sessa A., Esposito A., Iavicoli G. et al. Cardiovascular risk factors in renal transplant patients after switch from standard tacrolimus to prolonged-release tacrolimus// Transplant Proc. - 2012. - Vol. 44(7). - P. 1901-1906.
  26. Ho E.T., Wong G., Craig J.C. et al. Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review // Transplantation. - 2013. - Vol. 95(9). - P. 1120-1128.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>